ALZN
Price
$2.22
Change
-$0.14 (-5.93%)
Updated
Oct 17 closing price
Capitalization
8.44M
ASBP
Price
$0.34
Change
+$0.02 (+6.25%)
Updated
Oct 17 closing price
Capitalization
N/A
Interact to see
Advertisement

ALZN vs ASBP

Header iconALZN vs ASBP Comparison
Open Charts ALZN vs ASBPBanner chart's image
Alzamend Neuro
Price$2.22
Change-$0.14 (-5.93%)
Volume$71.59K
Capitalization8.44M
Aspire Biopharma Holdings
Price$0.34
Change+$0.02 (+6.25%)
Volume$1.4M
CapitalizationN/A
ALZN vs ASBP Comparison Chart in %
ALZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ASBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALZN vs. ASBP commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALZN is a Hold and ASBP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 19, 2025
Stock price -- (ALZN: $2.22 vs. ASBP: $0.34)
Brand notoriety: ALZN and ASBP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALZN: 61% vs. ASBP: 5%
Market capitalization -- ALZN: $8.44M vs. ASBP: $0
ALZN [@Biotechnology] is valued at $8.44M. ASBP’s [@Biotechnology] market capitalization is $0. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALZN’s FA Score shows that 1 FA rating(s) are green whileASBP’s FA Score has 1 green FA rating(s).

  • ALZN’s FA Score: 1 green, 4 red.
  • ASBP’s FA Score: 1 green, 4 red.
According to our system of comparison, both ALZN and ASBP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALZN’s TA Score shows that 3 TA indicator(s) are bullish while ASBP’s TA Score has 5 bullish TA indicator(s).

  • ALZN’s TA Score: 3 bullish, 6 bearish.
  • ASBP’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ASBP is a better buy in the short-term than ALZN.

Price Growth

ALZN (@Biotechnology) experienced а +1.83% price change this week, while ASBP (@Biotechnology) price change was +3.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALZN YTD gains are higher at: -78.736 vs. ASBP (-97.040).
ALZNASBPALZN / ASBP
Capitalization8.44MN/A-
EBITDA-6.17MN/A-
Gain YTD-78.736-97.04081%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash5.62MN/A-
Total Debt301KN/A-
TECHNICAL ANALYSIS
Technical Analysis
ALZNASBP
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
67%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
52%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
35%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
39%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
38%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
37%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 4 days ago
44%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 6 days ago
67%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
75%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
47%
View a ticker or compare two or three
Interact to see
Advertisement
ALZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ASBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FTV48.66-0.03
-0.06%
Fortive Corp
ACLS82.88-0.74
-0.88%
Axcelis Technologies
ENTX2.35-0.06
-2.49%
Entera Bio Ltd
AIRS9.12-0.37
-3.90%
AirSculpt Technologies
IDAI3.22-0.16
-4.73%
T Stamp Inc

ALZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALZN has been loosely correlated with SRPT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ALZN jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALZN
1D Price
Change %
ALZN100%
-5.93%
SRPT - ALZN
49%
Loosely correlated
-3.56%
VRAX - ALZN
46%
Loosely correlated
-1.06%
ASBP - ALZN
41%
Loosely correlated
+6.57%
SNSE - ALZN
41%
Loosely correlated
-33.43%
BPMUF - ALZN
36%
Loosely correlated
N/A
More

ASBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASBP has been loosely correlated with SPRO. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ASBP jumps, then SPRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASBP
1D Price
Change %
ASBP100%
+6.57%
SPRO - ASBP
58%
Loosely correlated
-5.96%
ALZN - ASBP
41%
Loosely correlated
-5.93%
OCUL - ASBP
25%
Poorly correlated
-2.95%
ORIC - ASBP
24%
Poorly correlated
-3.91%
ATXS - ASBP
24%
Poorly correlated
-0.91%
More